XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating activities:        
Net income/(loss) for the period $ (30,968) $ (3,125) $ (50,051) $ (6,145)
Depreciation of property and equipment 8,907 6,735 17,495 12,778
Impairment of property and equipment 74 0 2,016 27
Amortization of debt discount and issuance costs 893 147 1,131 267
Amortization of intangible assets 2,609 2,843 5,481 5,686
Net amortization contract costs (208) (245) (357) (472)
Accretion of contingent consideration 0 50 0 148
Deferred income taxes (recovery) (3,413) (1,053) (6,123) (1,739)
Excess tax benefits on share-based compensation expense 0 (4) (1) (55)
Net Right of use operating assets/Operating lease liability (15) (115) (97) (56)
Loss on disposal of domain names 0 0 0 2
Accretion of redeemable preferred shares 3,338 0 6,375 0
Loss on debt extinguishment 14,680 0 14,680 0
Loss (Gain) on change in the fair value of forward contracts 879 0 1,624 0
Amortization of discontinued cash flow hedge from Accumulated other income (572) 0 (1,144) 0
Stock-based compensation expense 2,052 1,436 4,298 2,828
Accounts receivable 661 2,865 (5,108) 1,053
Contract assets 693 (5,671) 2,884 (8,176)
Inventory (1,261) (1,238) (516) (1,519)
Prepaid expenses and deposits (2,117) 3,910 (3,443) 1,675
Deferred costs of fulfillment 472 819 (3,484) (1,130)
Income taxes recoverable (1,374) 1,086 (856) 1,568
Accounts payable (4,943) 3,891 (5,099) 6,158
Accrued liabilities 5,220 1,334 4,294 2,444
Customer deposits 3,322 950 3,665 327
Deferred revenue (464) (1,984) 5,839 2,384
Accreditation fees payable (52) (55) (341) (69)
Net cash provided by/(used in) operating activities (1,587) 12,576 (6,838) 17,984
Financing activities:        
Proceeds received on exercise of stock options 0 56 0 570
Proceeds from issuance of notes payable 227,258 0 227,258 0
Redeemable preferred shares redemption (45,718) 0 (45,718) 0
Proceeds from redeemable preferred shares 5,000 0 35,000 0
Deferred notes payable financing costs (6,745) 0 (6,745) 0
Deferred preferred financing costs 0 0 145 0
Contingent payments for acquisitions 0 (1,125) (1,600) (3,125)
Proceeds received on syndicated revolver 0 19,200 0 35,700
Repayment of syndicated revolver (7,000) 0 (9,800) 0
Payment of syndicated revolver costs (11) (88) (316) (265)
Net cash (used in) provided by financing activities 172,784 18,043 198,224 32,880
Investing activities:        
Additions to property and equipment (23,158) (30,288) (54,904) (53,342)
Acquisition of intangible assets (217) (22) (383) (117)
Net cash used in investing activities (23,375) (30,310) (55,287) (53,459)
Increase (decrease) in cash and cash equivalents, restricted cash, and restricted cash equivalents 147,822 309 136,099 (2,595)
Cash and cash equivalents, restricted cash, and restricted cash equivalents beginning of period 11,773 6,201 23,496 9,105
Cash and cash equivalents, restricted cash, and restricted cash equivalents end of period 159,595 6,510 159,595 6,510
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents within the interim consolidated balance sheets to the amounts shown in the interim consolidated statements of cash flows above:        
Cash and cash equivalents 147,864 6,510 147,864 6,510
Restricted cash included in funds held by trustee 3,361 0 3,361 0
Restricted cash included in secured notes reserve funds receivable 8,370 0 8,370 0
Total Cash and cash equivalents, restricted cash, and restricted cash equivalents end of period 159,595 6,510 159,595 6,510
Supplemental cash flow information:        
Interest paid 6,442 2,351 10,327 4,033
Income taxes paid, net 1,474 1,391 1,975 2,287
Supplementary disclosure of non-cash investing and financing activities:        
Property and equipment acquired during the period not yet paid for $ 2,638 $ 12,102 $ 2,638 $ 12,102